Hong Jen Chang

Hong Jen Chang

Président chez EUSOL BIOTECH CO.,LTD.
70 ans
Health Technology
Consumer Services
Finance

Profil

Hong Jen Chang currently works at YFY Biotech Management Co, as Chairman & Chief Executive Officer from 2015, MiCareo Taiwan Co., Ltd., as Chairman from 2011, Eusol Biotech Co., Ltd., as Chairman from 2024, TaiGen Biotechnology Co., Ltd., as Director, TaiGen Biopharmaceuticals Holdings Ltd., as Director from 2013, NeuroSky, Inc., as Director, Taiwan Genome Sciences, Inc., as Director, Taiwan Global BioFund, as Director, MiCareo, Inc., as Director, Medeon Biodesign, Inc., as Director from 2014, Excelsior Biopharma, Inc., as Director from 2015, Medeon Biosurgical, Inc., as Director, Sunny Pharma Holding Ltd., as Director, Medeon International, Inc., as Director, Acepodia Biotechnologies, Ltd., as Director, Acepodia, Inc., as Director from 2018, Formosa Pharmaceuticals, Inc., as Director from 2020, and Taiwan Pharmaceutical Manufactureres Association, as President from 2017.
Mr. Chang also formerly worked at National Health Insurance, as President & Chief Executive Officer, TBG Diagnostics Ltd., as Non-Executive Director, Mycenax Biotech, Inc., as Director, Pharmigene, Inc., as Director, Taiwan Liposome Co., Ltd., as Director from 2007 to 2019, TaiMed Biologics, Inc., as Director, TWi Biotechnology, Inc., as Director, Sunny Pharmtech Inc., as Director, Somnics, Inc., as Director, iXensor Co., Ltd., as Director, SyneuRx International (Taiwan) Corp., as Director, AP Biosciences, Inc., as Director, and TOT BIOPHARM International Co. Ltd., as Independent Non-Executive Director from 2019 to 2025.
Mr. Chang received his graduate degree in 1984 from National Taiwan University, undergraduate degree in 1982 from National Yang Ming University, and graduate degree in 1987 from Harvard T.H.
Chan School of Public Health.

Postes actifs de Hong Jen Chang

SociétésPosteDébut
TAIGEN BIOPHARMACEUTICALS HOLDINGS LIMITED Directeur/Membre du Conseil 01/04/2013
EUSOL BIOTECH CO.,LTD. Président 05/10/2009
FORMOSA PHARMACEUTICALS, INC. Directeur/Membre du Conseil 29/05/2020
MEDEON BIODESIGN, INC. Directeur/Membre du Conseil 14/01/2014
EXCELSIOR BIOPHARMA INC. Directeur/Membre du Conseil 12/04/2015
ACEPODIA, INC. Directeur/Membre du Conseil 17/01/2018
Directeur Général 13/07/2015
Sunny Pharma Holding Ltd.
Directeur/Membre du Conseil -
Medeon International, Inc.
Directeur/Membre du Conseil -
░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -
░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -

Anciens postes connus de Hong Jen Chang

SociétésPosteFin
░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░ ░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -
░░░░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -
Voir l'expérience en détail de Hong Jen Chang

Formation de Hong Jen Chang

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

59

Relations au 1er degré

34

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées34

Health Technology

Consumer Services

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Electronic Technology

Taiwan Genome Sciences, Inc.

Health Technology

Consumer Services

Finance

Consumer Services

Finance

Taiwan Pharmaceutical Manufactureres Association

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Electronic Technology

Health Technology

Health Technology

Health Technology

Health Technology

Medeon Biosurgical, Inc.

Sunny Pharma Holding Ltd.

Medeon International, Inc.

Health Technology

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Hong Jen Chang